KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap

scientific article published on 16 September 2019

KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41379-019-0365-Y
P698PubMed publication ID31527708

P50authorRoberto N. MirandaQ37842538
Francisco VegaQ40001462
P2093author name stringL Jeffrey Medeiros
P2860cites workNucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)Q24650427
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosisQ27851477
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcomaQ28242984
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasQ28299069
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's diseaseQ29619158
KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiationQ30433391
Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcomaQ33801927
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphomaQ33889296
Bone marrow failure associated with human herpesvirus 8 infection after transplantationQ33924650
Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.Q33939333
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman diseaseQ34157797
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman diseaseQ34431511
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseQ34636851
Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related OncogenesisQ35124404
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survivalQ36368882
Kaposi's sarcoma and its associated herpesvirusQ36487309
Competence and competition: the challenge of becoming a long-lived plasma cellQ36594883
Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related diseaseQ37635260
Long-lived autoreactive plasma cells drive persistent autoimmune inflammationQ37833902
Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 casesQ38025946
KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the LiteratureQ39156336
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.Q39232108
How I treat HHV8/KSHV-related diseases in posttransplant patients.Q39554617
KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivoQ40303480
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphomaQ40373195
HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expandsQ40441055
Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma).Q40492010
Primary human herpesvirus 8 infection in immunocompetent childrenQ40587020
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiationQ40660780
Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytesQ40913931
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ TransplantationQ41134958
Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problemsQ41666536
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignanciesQ41826795
Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's diseaseQ42602227
Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins.Q42646886
Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignanciesQ42665921
KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype.Q43010178
A case of successful management of HHV-8⁺, EBV⁺ germinotropic lymphoproliferative disorder (GLD).Q43632604
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphomaQ43813156
KSHV- and EBV-associated germinotropic lymphoproliferative disorder.Q44182960
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.Q44633978
KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphomaQ44857155
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphomaQ44987723
Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomasQ45000519
Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programsQ45012890
Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience.Q45347202
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasmQ45421951
Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.Q45761402
Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women.Q45767233
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.Q45769785
Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virusQ45846355
PD-L1 and Notch1 expression in KSHV/HHV-8 and EBV associated germinotropic lymphoproliferative disorder: case report and review of the literatureQ46108279
The full spectrum of Castleman disease: 273 patients studied over 20 yearsQ47578601
Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder.Q47590029
Cytokeratin-positive primary effusion lymphoma: a diagnostic challengeQ48113285
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.Q52008432
KSHV induces immunoglobulin rearrangements in mature B lymphocytes.Q52586065
Extracavitary/solid variant of primary effusion lymphomaQ57114623
Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other DiseasesQ57952920
Rituximab therapy for HIV-associated Castleman diseaseQ58004108
Lymph Nodes Involved by Multicentric Castleman Disease Among HIV-positive Individuals are Often Involved by Kaposi SarcomaQ59621846
Viral, immunologic, and clinical features of primary effusion lymphomaQ64101661
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients.Q64936532
Immunoblastic Lymphoma in Persons with AIDS-Associated Kaposi’s Sarcoma: a Role for Kaposi’s Sarcoma–Associated HerpesvirusQ73397236
Human herpesvirus 8-associated primary effusion lymphoma in HIV--patients: a clinicopidemiologic variant resembling classic Kaposi's sarcomaQ77900236
Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma arising in the subarachnoid spaceQ78143942
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD)Q79786222
Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth patternQ80575788
P433issue1
P304page(s)18-28
P577publication date2019-09-16
P1433published inModern PathologyQ15724578
P1476titleKSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap
P478volume33

Reverse relations

Q99563206[Primary effusion lymphoma in a HIV-negative patient: case report and literatures review]cites workP2860

Search more.